Geriatric evaluation in lung cancer care: a survey of daily practice
Abstract
Background: To identify ways to improve care for older lung cancer patients, we set out to examine how older lung cancer patients in the Netherlands are currently being analysed prior to oncological treatment and to explore the potential obstacles in the incorporation of a routinely performed geriatric evaluation. Methods: We sent a web-based survey to 138 Dutch pulmonologists specialized in lung cancer care between April and September 2015. Results: The response rate was 37%. According to the answers of the responding pulmonologist, a geriatric evaluation was available in 90% of the hospitals. This was performed routinely in a minority of the hospitals (45%) on the basis of age (18%), with use of some form of screening tool (27%), however mostly performed on ad hoc basis (56%). More than half (52%) of the respondents answered to be not, or not completely, satisfied with current geriatric evaluation. The main obstacles for implementing geriatric evaluation in standard care were lack of a structured format for this evaluation and lack of geriatric oncologic expertise. Conclusion: There is interest in the incorporation of a geriatric evaluation in the care for the heterogeneous elderly population with lung cancer. However, at the moment the optimal set-up for geriatric oncologic care is lacking. There seems to be no consensus about the optimal design in terms of patient selection, timing and use of screening tools. A closer collaboration between pulmonologists specialized in lung cancer care and geriatricians could help to improve appropriate care for elderly patients with lung cancer.
Downloads
Published
Issue
Section
License
OPEN ACCESS
All the articles of the European Journal of Oncology and Environmental Health are published with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/). This means that the author(s) retain copyright, but the content is free to download, distribute and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article.
The articles in the previous edition of the Journal (European Journal of Oncology) are made available online with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/).
Upon submission, author(s) grant the Journal the license to publish their original unpublished work within one year, and the non exclusive right to display, store, copy and reuse the content. The CC-BY Creative Commons attribution license enables anyone to use the publication freely, given appropriate attribution to the author(s) and citing the Journal as the original publisher. The CC-BY Creative Commons attribution license does not apply to third-party materials that display a copyright notice to prohibit copying. Unless the third-party content is also subject to a CC-BY Creative Commons attribution license, or an equally permissive license, the author(s) must comply with any third-party copyright notices.